Visiongain Publishes Veterinary Surgical Instruments Market Report 2021-2031

18 February 2021
Pharma

Visiongain has published a new report on Veterinary Surgical Instruments Market Report 2021-2031: Forecasts by Product (Sutures, Foreceps, Scissors, Electrosurgery Instruments, Cannulas), Animal (Canines, Felines, Large Animals), Application (Soft tissue, Sterilization, Gynaecology, Orthopaedic Surgery). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Veterinary Surgical Instruments market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031.

Increasing surgical techniques on pets in emerging countries is anticipated to drive market growth over the forecast period. The most common types of surgical procedures on pets are dental, cataract, hip dysplasia, spay or neuter, and wound repair.

Market Drivers
The increasing demand for veterinary surgical instruments is boosted by the growth in companion animal population combined with the growing demand for pet insurance, the increasing animal health awareness levels along with the increasing animal healthcare spending. Moreover, the growth in the number of veterinary consultants and the growth in the number of soft tissue injuries and trauma surgeries among pets are accountable for driving the inclusive growth of this market. The developing regions such as Asia-Pacific offer an added potential due to the large livestock population in this region and the escalating disposable incomes in this region.

Market Opportunities
The large animal segment dominated the market in owing to the increasing incidence of chronic diseases of equine animals, awareness among government animal healthcare organizations, and rising expenditure on animal healthcare in developing countries. The World Health Organization (WHO) is involving in various activities to address health threats at the human-animal-ecosystem interface including antimicrobial resistance, food-borne zoonoses, and food safety. This is anticipated to drive the need for better treatment facilities equipped with veterinary surgical instruments for companion animals.

The small animal segment is expected to exhibit a significant growth rate in the veterinary surgical instrument market due to the increasing small animal ownership and demand for efficient animal care. According to a report by the Humane Society of the United States.
The above mentioned factors are accountable for a lucrative growth prospects in the veterinary surgical instruments market.

Competitive Landscape
The global veterinary surgical instruments market is categorized by the existence of a large number of players. Amongst intense market competition, major players are constantly concentrating on accomplishing higher market shares through new product launches, and collaborations and agreements in the market. The global market is fragmented in nature, with a large number of companies incessantly trying to mark their existence. The market is led by B. Braun Vet Care GmbH (Germany), Medtronic Plc (Ireland), Ethicon Inc. (U.S.), and JORGEN KRUSSE A/S (Denmark). Other players in this market are Jorgensen Laboratories (U.S.), Smiths Group Plc (U.K.), Neogen Corporation (U.S.),Integra LifeSciences Holdings Corporation (U.S.), STERIS Corporation (U.S.), DRE Veterinary (U.S.), GerMedUSA, Inc. (U.S.), Surgical Holdings (U.K.), Sklar Surgical Instruments (U.S.), World Precision Instruments, Inc. (U.S.), Surgical Direct (U.S.), Antibe Therapeutics Inc. (Canada), and iM3 (U.S.).

Recent Developments
• In July 2018, B. Braun Vet Care signed a contract with CP Medical wherein the company would market B. Braun’s veterinary Infusion Therapy product range in U.S. and Canada.
• In 2019, ApexVetsintroduced single-use surgical instruments for veterinary practice.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Big Data Analytics in Healthcare Market Report 2021-2031

Healthcare has never been more personalized and affordable to anyone. Digital consulting applications use artificial intelligence to provide medical advice based on customized medical history record reviews and general medical information derived from big data inferences.

13 May 2021

Read

Visiongain Publishes NGS-Based RNA Sequencing Market Report 2021-2031

The market is expected to be driven by key factors such as rising cancer prevalence, government funding support in genetic research and technological advancements taking place in the biological research field. In addition, the market is predicted to gain huge traction in the developing countries.

11 May 2021

Read

Visiongain Publishes Single-Use Bioreactors Market Report 2021-2031

Strong product portfolio in the market is one of the major factors accelerating the growth of the market as availability of variants in the single-use systems allows targeted users more options.

11 May 2021

Read

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever